Showing 321 - 340 results of 11,872 for search '(( 5 ((ng decrease) OR (nn decrease)) ) OR ( 100 ((nm decrease) OR (a decrease)) ))', query time: 0.51s Refine Results
  1. 321

    Structural Characterization of Ceria-Supported Pt Nanoparticles by Flame-Assisted Spray Pyrolysis Using a Burner Diffusion Flame by Tsuyoshi Nagasawa (8680269)

    Published 2021
    “…The synthesized particles mainly consist of 100 nm-scale CeO<sub>2</sub> with 10 nm-scale Pt and aggregation of small CeO<sub>2</sub> less than 10 nm with highly dispersed Pt at a maximum flame temperature <i>T</i><sub>max</sub> ≈ 1800 K. …”
  2. 322

    Structural Characterization of Ceria-Supported Pt Nanoparticles by Flame-Assisted Spray Pyrolysis Using a Burner Diffusion Flame by Tsuyoshi Nagasawa (8680269)

    Published 2021
    “…The synthesized particles mainly consist of 100 nm-scale CeO<sub>2</sub> with 10 nm-scale Pt and aggregation of small CeO<sub>2</sub> less than 10 nm with highly dispersed Pt at a maximum flame temperature <i>T</i><sub>max</sub> ≈ 1800 K. …”
  3. 323
  4. 324

    Data Sheet 1_Semaglutide attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis of cardiomyocytes via activation of PKC-S100A9 axis.pdf by Yan Liu (25061)

    Published 2025
    “…In vitro, experiments showed that semaglutide decreased the expression of S100A9 by activating the Protein Kinase C(PKC) pathway, thus inhibiting ferroptosis in cardiomyocytes.…”
  5. 325

    Data Sheet 2_Semaglutide attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis of cardiomyocytes via activation of PKC-S100A9 axis.docx by Yan Liu (25061)

    Published 2025
    “…In vitro, experiments showed that semaglutide decreased the expression of S100A9 by activating the Protein Kinase C(PKC) pathway, thus inhibiting ferroptosis in cardiomyocytes.…”
  6. 326

    Table 1_Semaglutide attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis of cardiomyocytes via activation of PKC-S100A9 axis.docx by Yan Liu (25061)

    Published 2025
    “…In vitro, experiments showed that semaglutide decreased the expression of S100A9 by activating the Protein Kinase C(PKC) pathway, thus inhibiting ferroptosis in cardiomyocytes.…”
  7. 327

    Decreased myofibroblasts in the peritumoral region and high expression of MMP-7 in Pan02 S.C. tumor of <i>S100a4-Cre; Ext1</i><sup><i>f/f</i></sup> mice. by Ayumi Niwa (6256790)

    Published 2023
    “…<p>(A) Immunostaining of α-smooth muscle actin (αSMA)-positive spindle cells, i.e., myofibroblasts, in the peritumoral region of Pan02 S.C. pancreatic tumors in <i>S100a4-Cre; Ext1</i><sup><i>f/f</i></sup> and control mice (left). …”
  8. 328
  9. 329
  10. 330
  11. 331
  12. 332
  13. 333
  14. 334

    Image_4_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
  15. 335

    Image_5_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
  16. 336

    Table_1_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.docx by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
  17. 337

    Image_2_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
  18. 338

    Image_3_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
  19. 339

    Image_6_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”
  20. 340

    Table_2_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.docx by Casey E. Vantucci (10528263)

    Published 2022
    “…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”